Oncology, Screening & Prevention
Detecting Lung Cancer Early: Lung Cancer Screening in the Family Medicine Practice
Lung cancer is the leading cause for cancer-related deaths in Canada. There is evidence that early detection of lung cancer with low-dose computed tomography (LDCT) can reduce lung cancer mortality. The purpose of this program is to outline existing guidance on lung cancer screening with LDCT for primary care physicians in Canada. This program will […]
DURATION
30 min
PROFESSION
Physician
# OF CREDITS
0.5
ACCREDITATION
Mainpro+
EXPIRY DATE
2023-05-01
Lung cancer is the leading cause for cancer-related deaths in Canada. There is evidence that early detection of lung cancer with low-dose computed tomography (LDCT) can reduce lung cancer mortality. The purpose of this program is to outline existing guidance on lung cancer screening with LDCT for primary care physicians in Canada. This program will also highlight the mortality benefits of diagnosing lung cancer at an early stage and discuss key strategies for patient engagement in the family medicine practice.
This program has received financial support from AstraZeneca in the form of an unrestricted educational grant.
Faculty
Stephanie Snow, MD, FRCPC
Stephen Lam, MD, FRCPC
Jeffrey Habert, MD, CCFP, FCFP
Christine Palmay, HBArtSci, MD, CCFP, FCFP
Deanna Telner, MD, Med, CFPC, FCFP
Learning objectives
At the end of this course, learners will be able to:
- Recognize the benefits of lung cancer screening on patient outcomes based on results of pilots and trials in and outside of Canada
- Understand Canadian expert consensus recommendations on lung cancer screening
Describe the guidance on eligibility and referrals for existing lung cancer screening programs and pilots in Canada- Outline the impact of smoking cessation on lung cancer mortality